Does Medicaid Cover GLP-1 Weight Loss Drugs? (2026 State Guide)
Medicaid coverage for GLP-1 weight loss medications varies dramatically by state. 33 states currently cover GLP-1s for weight management, 3 cover only for diabetes, and 14 exclude coverage entirely. Find your state below and learn what to do if you are not covered.
Medicaid GLP-1 Coverage at a Glance
As of early 2026, the majority of states have added at least one GLP-1 medication to their Medicaid formularies for weight management. This represents significant progress — in 2024, only about 20 states covered these medications. However, coverage does not guarantee easy access — most states require prior authorization and have strict eligibility criteria.
State-by-State Coverage Map
Click your state for detailed coverage information, PA requirements, and covered medications. Coverage status reflects fee-for-service Medicaid — managed care plans may differ.
| State | Weight Loss Coverage | Notes | Details |
|---|---|---|---|
| Alabama | Limited | Diabetes only | View Details |
| Alaska | Covered | Weight loss covered | View Details |
| Arizona | Covered | Weight loss covered | View Details |
| Arkansas | Not Covered | Excluded | View Details |
| California | Covered | Weight loss covered | View Details |
| Colorado | Covered | Weight loss covered | View Details |
| Connecticut | Covered | Weight loss covered | View Details |
| Delaware | Covered | Weight loss covered | View Details |
| Florida | Not Covered | Excluded | View Details |
| Georgia | Not Covered | Excluded | View Details |
| Hawaii | Covered | Weight loss covered | View Details |
| Idaho | Not Covered | Excluded | View Details |
| Illinois | Covered | Weight loss covered | View Details |
| Indiana | Covered | Weight loss covered | View Details |
| Iowa | Covered | Weight loss covered | View Details |
| Kansas | Not Covered | Excluded | View Details |
| Kentucky | Covered | Weight loss covered | View Details |
| Louisiana | Covered | Weight loss covered | View Details |
| Maine | Covered | Weight loss covered | View Details |
| Maryland | Covered | Weight loss covered | View Details |
| Massachusetts | Covered | Weight loss covered | View Details |
| Michigan | Covered | Weight loss covered | View Details |
| Minnesota | Covered | Weight loss covered | View Details |
| Mississippi | Not Covered | Excluded | View Details |
| Missouri | Limited | Diabetes only | View Details |
| Montana | Covered | Weight loss covered | View Details |
| Nebraska | Not Covered | Excluded | View Details |
| Nevada | Covered | Weight loss covered | View Details |
| New Hampshire | Covered | Weight loss covered | View Details |
| New Jersey | Covered | Weight loss covered | View Details |
| New Mexico | Covered | Weight loss covered | View Details |
| New York | Covered | Weight loss covered | View Details |
| North Carolina | Covered | Weight loss covered | View Details |
| North Dakota | Not Covered | Excluded | View Details |
| Ohio | Covered | Weight loss covered | View Details |
| Oklahoma | Not Covered | Excluded | View Details |
| Oregon | Covered | Weight loss covered | View Details |
| Pennsylvania | Covered | Weight loss covered | View Details |
| Rhode Island | Covered | Weight loss covered | View Details |
| South Carolina | Not Covered | Excluded | View Details |
| South Dakota | Not Covered | Excluded | View Details |
| Tennessee | Limited | Diabetes only | View Details |
| Texas | Not Covered | Excluded | View Details |
| Utah | Covered | Weight loss covered | View Details |
| Vermont | Covered | Weight loss covered | View Details |
| Virginia | Covered | Weight loss covered | View Details |
| Washington | Covered | Weight loss covered | View Details |
| West Virginia | Not Covered | Excluded | View Details |
| Wisconsin | Covered | Weight loss covered | View Details |
| Wyoming | Not Covered | Excluded | View Details |
Coverage data last verified March 2026. Medicaid policies change frequently — always confirm with your state's Medicaid program directly. Managed care organizations may have different coverage than fee-for-service Medicaid.
How to Check Your Coverage
Do not rely solely on the table above — your specific Medicaid plan may have different rules. Here are the most reliable ways to verify your coverage.
Call Your Medicaid Plan Directly
Call the member services number on the back of your Medicaid card. Ask specifically: 'Does my plan cover Wegovy (semaglutide) or Zepbound (tirzepatide) for weight management?' Get the answer in writing or note the reference number for the call. If you are in a managed care plan, call the MCO — not the state Medicaid office.
Check the Preferred Drug List (PDL)
Every state Medicaid program publishes a Preferred Drug List (formulary) on their website. Search for 'semaglutide,' 'tirzepatide,' 'Wegovy,' 'Zepbound,' 'Ozempic,' or 'Mounjaro.' If the medication is on the PDL, it is covered — but likely requires prior authorization. If it is not listed, it may still be available through a non-preferred exception.
Ask Your Prescriber to Run a Benefits Check
Your doctor's office can electronically verify your specific coverage through their pharmacy benefits system. This is the most accurate method because it checks your individual plan, not general state policy. The benefits check will also reveal prior authorization requirements, quantity limits, and your expected copay (usually $0-$3 for Medicaid).
Contact Your State Medicaid Agency
If you cannot get a clear answer from the steps above, contact your state's Medicaid agency directly. Ask for the pharmacy benefits department. They can confirm whether GLP-1 medications are covered for weight management, what the PA criteria are, and whether any recent policy changes are pending.
What to Do If Your State Doesn't Cover GLP-1s
Living in a state without Medicaid GLP-1 coverage does not mean you are out of options. Here are alternative pathways to access these medications.
Manufacturer Patient Assistance
Novo Nordisk (Wegovy/Ozempic) and Eli Lilly (Zepbound/Mounjaro) both offer Patient Assistance Programs for uninsured and underinsured patients. Medicaid patients who are denied GLP-1 coverage may qualify. These programs provide medication at no cost for eligible households.
View savings programs→Diabetes Indication Workaround
If you have type 2 diabetes in addition to obesity, your doctor can prescribe Ozempic or Mounjaro for the diabetes indication. Virtually all state Medicaid programs cover GLP-1s for diabetes. The medication is the same — only the prescribing indication differs.
Ozempic cost guide→Managed Care Plan Differences
If your state uses Medicaid managed care, different MCOs within the same state may have different formularies. During open enrollment, you may be able to switch to an MCO that covers GLP-1 medications for weight loss. Contact each available MCO to compare coverage.
Cost center overview→Clinical Trial Enrollment
Many GLP-1 clinical trials provide medication at no cost. ClinicalTrials.gov lists active studies recruiting participants. Trials for next-generation GLP-1 medications (survodutide, orforglipron, retatrutide) are actively enrolling and may be an option.
Next-gen GLP-1 guide→The Appeal Process: Step by Step
If your Medicaid program denies coverage for a GLP-1 medication, you have the right to appeal. Federal law requires all Medicaid programs to provide a formal appeals process. Here is how to maximize your chances of success.
Review the Denial Letter Carefully
The denial letter must explain why coverage was denied and how to appeal. Common denial reasons include: not meeting BMI criteria, not completing required prior treatments (step therapy), or the medication not being on the formulary. Understanding the specific reason helps you target your appeal.
Gather Clinical Documentation
Collect: your complete medical history, documented BMI measurements, list of prior weight management attempts (diets, exercise programs, other medications), comorbidity records (diabetes, sleep apnea, hypertension), and any specialist referrals. The more thorough the documentation, the stronger the appeal.
Get a Letter of Medical Necessity
Your prescriber writes a detailed letter explaining why GLP-1 therapy is medically necessary for you specifically. This should address the denial reason directly, cite clinical evidence supporting GLP-1 use for your conditions, and explain why alternatives are inadequate.
Submit the Appeal Within the Deadline
Most states allow 30-60 days to file an appeal. Submit everything in writing — keep copies of all documents. Send via certified mail or the electronic portal if available. Include the denial reference number, your Medicaid ID, and all supporting documentation.
Request a Fair Hearing If Needed
If the first appeal is denied, you can request a fair hearing before an administrative law judge. This is an independent review of your case. You have the right to present evidence, bring witnesses (including your doctor), and be represented by an advocate. Fair hearing requests must typically be filed within 90 days of the appeal denial.
The Evolving Landscape of Medicaid GLP-1 Coverage
Medicaid coverage of GLP-1 medications for weight management is one of the most rapidly evolving areas of U.S. healthcare policy. Historically, most Medicaid programs excluded anti-obesity medications entirely, following a 2003 federal rule that allowed states to exclude drugs used for "anorexia, weight loss, or weight gain" from Medicaid coverage. This exemption predated the modern understanding of obesity as a chronic disease and the development of effective pharmaceutical treatments.
The landscape began shifting dramatically in 2024-2025 as clinical evidence mounted that GLP-1 medications not only reduce weight but also lower cardiovascular risk, improve kidney function, and reduce healthcare utilization for obesity-related conditions. Several economic analyses found that covering GLP-1s could be cost-effective for Medicaid programs within 5-7 years by reducing spending on diabetes management, cardiovascular events, and orthopedic procedures.
The Cost Challenge for State Budgets
The primary barrier to universal Medicaid GLP-1 coverage remains cost. With approximately 80 million Medicaid enrollees nationwide, and an estimated 20-30% meeting criteria for GLP-1 therapy, the potential budget impact is enormous. Even with negotiated Medicaid rebates (which reduce the effective cost to Medicaid below the list price), the annual cost of covering all eligible beneficiaries has been estimated at $13-26 billion. States must balance this against other healthcare priorities and budget constraints. This is why coverage has expanded incrementally, state by state, rather than through a sweeping federal mandate.
Frequently Asked Questions
Does Medicaid cover Ozempic for weight loss?
It depends on your state and the indication. Ozempic is FDA-approved for type 2 diabetes, not weight loss. Most Medicaid programs cover Ozempic for diabetes. For weight loss, your doctor would need to prescribe Wegovy (which is the weight-loss-approved form of semaglutide) or Zepbound (tirzepatide). Whether your state's Medicaid covers these weight-loss-specific medications varies — 36 states currently cover at least one GLP-1 for weight management.
How do I check if my state Medicaid covers GLP-1 medications?
Three ways: (1) Call the number on the back of your Medicaid card and ask specifically about coverage for Wegovy or Zepbound for weight management, (2) Check your state's Medicaid preferred drug list (PDL) on their website, or (3) Ask your prescriber's office to run a benefits verification — they can check coverage and prior authorization requirements electronically.
What if my state Medicaid doesn't cover GLP-1 for weight loss?
You have several options: (1) If you also have type 2 diabetes, your doctor can prescribe Ozempic or Mounjaro for the diabetes indication, which is covered in virtually all states, (2) Apply for manufacturer patient assistance programs (Novo Nordisk PAP or Lilly Cares), (3) Check if your state's Medicaid managed care organization (MCO) has a different formulary than fee-for-service Medicaid, or (4) Advocate for change — contact your state representative to support Medicaid GLP-1 coverage expansion.
Can I appeal a Medicaid denial for GLP-1 medication?
Yes. All Medicaid programs must provide an appeals process by federal law. You have 30-60 days to file an appeal (varies by state). Include a letter of medical necessity from your prescriber documenting your BMI, comorbidities, failed prior treatments, and why GLP-1 therapy is medically necessary. Many initial denials are overturned on appeal, especially when strong clinical documentation is provided.
Does Medicaid require prior authorization for GLP-1 drugs?
Almost always, yes. Most state Medicaid programs require prior authorization for GLP-1 medications, even when they are on the preferred drug list. Typical PA requirements include: documented BMI of 30+ (or 27+ with comorbidities), failure of at least one prior weight management intervention (diet/exercise program), and no contraindications. Your prescriber's office handles the PA submission.
Are Medicaid managed care plans different from fee-for-service Medicaid?
Yes, and this matters. Most Medicaid beneficiaries are enrolled in managed care organizations (MCOs) that may have different formularies and coverage policies than your state's fee-for-service Medicaid. Some MCOs cover GLP-1 medications for weight loss even in states where fee-for-service Medicaid does not. Check with your specific MCO for their formulary and coverage criteria.
Is there a federal mandate to cover GLP-1 medications under Medicaid?
Not yet, but there is growing political pressure. Several federal proposals in 2025-2026 have sought to require Medicaid coverage of FDA-approved anti-obesity medications. The argument: covering GLP-1s could reduce long-term Medicaid costs for obesity-related conditions (heart disease, diabetes, joint replacement). However, the short-term cost — estimated at $13-26 billion annually if all eligible Medicaid beneficiaries used GLP-1s — has slowed legislative progress.
Explore Other Savings Options
Medicaid is not the only path to affordable GLP-1 medications. Compare all available cost-reduction strategies in our comprehensive cost guides.
Disclaimer: Medicaid coverage information is provided for educational purposes and may not reflect the most current state policies. Medicaid programs change frequently. Always verify coverage directly with your state Medicaid agency or managed care plan. GLP-1 Watchdog is not affiliated with any state Medicaid program or pharmaceutical manufacturer.